The Cabinet of Ministers expanded the affordable medicines program with the “rheumatic diseases” section and included the international generic names “chloroquine” and “hydroxychloroquine” in the list of electronic prescription drugs.
This was announced at a cabinet meeting on April 15 by Health Minister Maxim Stepanov, reports a correspondent for Ukrinform.
“The draft resolution proposes to broaden the reimbursement program” Affordable medicines “with medicines for the treatment of rheumatic diseases and to introduce the release of this group of medicines in accordance with electronic prescriptions. In particular, it is proposed to supplement the list of international generic names with a section on rheumatic diseases, which will include drugs such as chloroquine and hydroxychloroquine, “said Stepanov.
See also: Plaquenil in the treatment of coronavirus can only be used in hospitals – Ministry of Health
Stepanov explained the need for such changes by the fact that after the world began to use drugs such as Plaquenil (with the active substance hydroxychloroquine – ed.), For the treatment of COVID-19 and the introduction of chloroquine and hydroxychloroquine in the Ukrainian protocol for the treatment of this disease, it is a drug the remedy has disappeared from Ukrainian pharmacies, which has compromised the treatment of people with rheumatic diseases.
The government has also modified the extension of the provisions relating to the public registration of medicines. This applies to medicines supplied to Ukraine as part of international purchases.
According to the materials: ukrinform.ru